Literature DB >> 27737787

Ineffectiveness of rabies vaccination alone for post-exposure protection against rabies infection in animal models.

Yi Zhang1, Shoufeng Zhang2, Lietao Li1, Rongliang Hu2, Haixiang Lin1, Hua Liu1, Fang Liu1, Hui Shao1, Yuan Liu3.   

Abstract

Most reported vaccination failures among rabies-exposed patients were due to fail to timely co-administer rabies immunoglobulin (RIG). Considering that such protection failure might be caused by low antigen titers in the vaccine, scientists improved antigen titers to 4.0 IU or even higher, yet the failure remained. Therefore, it becomes vital to develop more efficacious vaccine against rabies. In our evaluation of a novel PIKA rabies vaccine, we used multiple animal models (beagles, golden hamsters and Kunming mice) to mimic post-exposure scenarios. All animals were challenged with wild-type rabies virus, followed by vaccination with either rabies vaccines commercially available or PIKA rabies vaccines. As 100% of animals survived after administration of traditional rabies vaccines and rabies immunoglobulin, 80% of animals survived with rabies immunoglobulin alone. Strikingly, animals receiving traditional rabies vaccines alone showed extremely low survival rates, indicating insignificant benefit for exposed animals (p > 0.05, compared to unvaccinated control groups). To the contrary, 40-80% of animals receiving the experimental PIKA rabies vaccines were protected (p < 0.05, compared to unvaccinated control groups). If the above results are fully confirmed, we may conclude that currently as high as 99% of post-exposure patients who are seeking protection against rabies, but only receiving rabies vaccination, could be meaningless.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adjuvant; Challenge; Post-exposure prophylaxis; Post-exposure therapy; Protection; Rabies vaccine

Mesh:

Substances:

Year:  2016        PMID: 27737787     DOI: 10.1016/j.antiviral.2016.10.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.

Authors:  Julio Alvarez; Søren Saxmose Nielsen; Emmanuelle Robardet; Arjan Stegeman; Steven Van Gucht; Vlad Vuta; Sotiria-Eleni Antoniou; Inma Aznar; Alexandra Papanikolaou; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-06-02

Review 2.  Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.

Authors:  Charles Rupprecht; Ivan Kuzmin; Francois Meslin
Journal:  F1000Res       Date:  2017-02-23

3.  Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.

Authors:  Nigel C L Kwan; Akio Yamada; Katsuaki Sugiura
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

4.  Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines.

Authors:  Aurore Lebrun; Samantha Garcia; Jianwei Li; Rhonda B Kean; D Craig Hooper
Journal:  Trop Med Infect Dis       Date:  2017-07-04

Review 5.  TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection.

Authors:  Allison M Owen; Jessica B Fults; Naeem K Patil; Antonio Hernandez; Julia K Bohannon
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.